- Home
- IPHA vs OGI Comparison
IPHA vs OGI Comparison
Compare IPHA & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- OGI
- Stock Information
- Founded
- IPHA 1999
- OGI 2013
- Country
- IPHA France
- OGI Canada
- Employees
- IPHA N/A
- OGI N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- IPHA Health Care
- OGI Health Care
- Exchange
- IPHA Nasdaq
- OGI Nasdaq
- Market Cap
- IPHA 171.6M
- OGI 176.1M
- IPO Year
- IPHA 2019
- OGI N/A
- Fundamental
- Price
- IPHA $2.25
- OGI $1.80
- Analyst Decision
- IPHA Strong Buy
- OGI
- Analyst Count
- IPHA 1
- OGI 0
- Target Price
- IPHA $11.50
- OGI N/A
- AVG Volume (30 Days)
- IPHA 5.5K
- OGI 388.2K
- Earning Date
- IPHA 09-12-2024
- OGI 08-13-2024
- Dividend Yield
- IPHA N/A
- OGI N/A
- EPS Growth
- IPHA N/A
- OGI N/A
- EPS
- IPHA N/A
- OGI N/A
- Revenue
- IPHA $36,202,722.00
- OGI $110,297,722.00
- Revenue This Year
- IPHA N/A
- OGI $8.76
- Revenue Next Year
- IPHA $105.84
- OGI $14.04
- P/E Ratio
- IPHA N/A
- OGI N/A
- Revenue Growth
- IPHA N/A
- OGI 2.33
- 52 Week Low
- IPHA $1.81
- OGI $0.97
- 52 Week High
- IPHA $3.15
- OGI $2.91
- Technical
- Relative Strength Index (RSI)
- IPHA 49.51
- OGI 47.72
- Support Level
- IPHA $2.07
- OGI $1.76
- Resistance Level
- IPHA $2.29
- OGI $2.00
- Average True Range (ATR)
- IPHA 0.10
- OGI 0.09
- MACD
- IPHA -0.01
- OGI -0.01
- Stochastic Oscillator
- IPHA 52.85
- OGI 28.57
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.